Experimental Drug Helps Body Fight Advanced Melanoma: Study
Some patients kept disease at bay for more than a year after last dose of nivolumabContinue Reading
Some patients kept disease at bay for more than a year after last dose of nivolumabContinue Reading
Some patients kept disease at bay for more than a year after last dose of nivolumabContinue Reading
Those lacking health coverage are often male, black or Hispanic and from the South, study findsContinue Reading
But FDA assessment calls for further look at injectable type-2 treatmentsContinue Reading
More than 15 million cosmetic surgeries and minimally invasive procedures performed in 2013Continue Reading
Researchers note that Africans without any dark pigment often die young of the diseaseContinue Reading
Jury still out on whether multivitamins prevent cancer or heart disease, task force saysContinue Reading
Researchers still found ‘excellent’ survival rates for both primary, secondary diseaseContinue Reading
Risk was highest when men had high or low levels of selenium already in their bodyContinue Reading
Risk was highest when men had high or low levels of selenium already in their bodyContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.